TERN - Terns Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TERN is currently covered by 9 analysts with an average price target of $11.8. This is a potential upside of $9.02 (324.46%) from yesterday's end of day stock price of $2.78.

Terns Pharmaceuticals's activity chart (see below) currently has 20 price targets and 49 ratings on display. The stock rating distribution of TERN is 73.53% BUY and 26.47% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.33% with an average time for these price targets to be met of 64.4 days.

Highest price target for TERN is $26, Lowest price target is $7.5, average price target is $16.81.

Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 20-Apr-2025.

Currently out of the existing stock ratings of TERN, 25 are a BUY (73.53%), 9 are a HOLD (26.47%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$20

$16.96 (557.89%)

$20

24 days ago
(20-Apr-2025)

0/12 (0%)

$17.29 (638.01%)

Hold

$7.5

$4.46 (146.71%)

$7.5

5 months 11 days ago
(03-Dec-2024)

8/10 (80%)

$0.42 (5.93%)

89

Buy

$20

$16.96 (557.89%)

$17

5 months 12 days ago
(02-Dec-2024)

0/2 (0%)

$13.64 (214.47%)

Buy

$26

$22.96 (755.26%)

$19

7 months 29 days ago
(15-Sep-2024)

0/4 (0%)

$16.59 (176.30%)

Buy

$18

$14.96 (492.11%)

$19

1 years 1 months 18 days ago
(26-Mar-2024)

0/2 (0%)

$11.84 (192.21%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TERN (Terns Pharmaceuticals) average time for price targets to be met?

On average it took 64.4 days on average for the stock forecasts to be realized with a an average price target met ratio 21.33

Which analyst has the current highest performing score on TERN (Terns Pharmaceuticals) with a proven track record?

ERIC JOSEPH

Which analyst has the most public recommendations on TERN (Terns Pharmaceuticals)?

Eric Joseph works at JPMORGAN and has 4 price targets and 2 ratings on TERN

Which analyst is the currently most bullish on TERN (Terns Pharmaceuticals)?

Etzer Darout with highest potential upside - $22.96

Which analyst is the currently most reserved on TERN (Terns Pharmaceuticals)?

Ritu Baral with lowest potential downside - -$0

Terns Pharmaceuticals in the News

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

FOSTER CITY, Calif., May 02, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity, today announced that it has granted as of May 1, 2025 equity inducement awards to two new employees...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?